ATE375514T1 - Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion - Google Patents

Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion

Info

Publication number
ATE375514T1
ATE375514T1 AT00910338T AT00910338T ATE375514T1 AT E375514 T1 ATE375514 T1 AT E375514T1 AT 00910338 T AT00910338 T AT 00910338T AT 00910338 T AT00910338 T AT 00910338T AT E375514 T1 ATE375514 T1 AT E375514T1
Authority
AT
Austria
Prior art keywords
methods
compounds
cruzi infection
compositions
trypanosoma cruzi
Prior art date
Application number
AT00910338T
Other languages
English (en)
Inventor
Steven Reed
Yasir Skeiky
Michael Lodes
Raymond Houghton
John Smith
Patricia Mcneill
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE375514T1 publication Critical patent/ATE375514T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
AT00910338T 1999-02-24 2000-02-24 Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion ATE375514T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/256,976 US6419933B1 (en) 1995-11-14 1999-02-24 Compounds and methods for the detection and prevention of T.cruzi infection

Publications (1)

Publication Number Publication Date
ATE375514T1 true ATE375514T1 (de) 2007-10-15

Family

ID=22974378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910338T ATE375514T1 (de) 1999-02-24 2000-02-24 Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion

Country Status (9)

Country Link
US (1) US6419933B1 (de)
EP (1) EP1155322B1 (de)
JP (1) JP2002537783A (de)
AT (1) ATE375514T1 (de)
AU (1) AU3245000A (de)
CA (1) CA2362608A1 (de)
DE (1) DE60036692D1 (de)
MX (1) MXPA01008621A (de)
WO (1) WO2000050897A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875584B1 (en) * 1999-03-02 2005-04-05 University Of Georgia Research Foundation, Inc. Prophylactic and therapeutic immunization against protozoan infection and disease
US7888135B2 (en) * 2004-04-23 2011-02-15 University Of Georgia Research Foundation, Inc. Diagnostic assay for Trypanosoma cruzi infection
US7780969B2 (en) * 2005-07-15 2010-08-24 University Of Georgia Research Foundation, Inc. Trypanosoma cruzi proteome compositions and methods
AU2006311873B2 (en) * 2005-11-03 2011-10-06 Access To Advanced Health Institute Compositions and methods for the detection of Trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
WO2008057961A2 (en) * 2006-11-02 2008-05-15 Infectious Disease Research Institute Compositions and methods for the detection of trypanosoma cruzi infection
US20080107692A1 (en) * 2006-11-02 2008-05-08 Infectious Disease Research Institute Compositions and methods for the detection of trypanosoma cruzi infection
CA2700000A1 (en) * 2007-07-30 2009-02-05 Rick L. Tarleton Diagnostic assay for trypanosoma cruzi infection
JP5611834B2 (ja) 2007-12-27 2014-10-22 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 抗Ｔ．ｃｒｕｚｉ抗体及び使用方法
FR2945290A1 (fr) * 2009-05-07 2010-11-12 Maan Zrein Anticorps biomarqueur et dispositif de diagnostic pour la detection de certaines maladies auto-immunes
ES2373262B1 (es) * 2010-07-16 2013-05-06 Consejo Superior De Investigaciones Científicas (Csic) Método de diagnóstico diferencial de la enfermedad de chagas.
ITUA20161850A1 (it) * 2016-03-21 2017-09-21 Fluidia S R L Metodo per la valutazione quantitativa in biologico, della forma fosforilata e non fosforilata di RKIP

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (de) 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US5916572A (en) 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection

Also Published As

Publication number Publication date
US6419933B1 (en) 2002-07-16
CA2362608A1 (en) 2000-08-31
AU3245000A (en) 2000-09-14
EP1155322A1 (de) 2001-11-21
JP2002537783A (ja) 2002-11-12
WO2000050897A1 (en) 2000-08-31
MXPA01008621A (es) 2002-04-24
EP1155322B1 (de) 2007-10-10
DE60036692D1 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
FI870447A (fi) Htlv-iii-hoeljepeptider.
DE60036692D1 (de) Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
ATE272113T1 (de) Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
NO20004413D0 (no) HIV peptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangmÕte for pÕvisning av antistoffer som blir infusert av HIV
BR9913446A (pt) Produtos de aglicona e métodos de uso
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
MX9803841A (es) Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.
DE60042816D1 (de) T-helferzellen-epitope
DE60019178D1 (de) Neue Antigenklasse von Geflügelreoviren
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
BR9813637A (pt) Compostos e métodos para a detecção e prevençãode infecção por t. cruzi
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
TR200003467T2 (tr) Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
DE69231495D1 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
ATE286511T1 (de) Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
DK1077999T3 (da) Moraxella catarrhalis-proteiner
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
AR012896A1 (es) Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
FI913475A0 (fi) Klass ii protein med immunologiska baerar- och foerstaerkningsegenskaper fraon yttermembranen i neisseria meningitidis och vaccin innehaollande detta.
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties